Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Pharmaxis Ltd ( (AU:SNT) ) has issued an announcement.
Syntara Limited reported a significant increase in revenues from ordinary activities and other income for the half-year ended 31 December 2024, with a 337.94% rise to $3,070,000. The company also reported a substantial reduction in its loss from ordinary activities after tax, which decreased by 54.3% to $2,716,000 compared to the previous period. Despite the improved financial performance, no dividends were declared or paid during the current financial period.
More about Pharmaxis Ltd
YTD Price Performance: -2.50%
Average Trading Volume: 5,587,286
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$126.6M
Find detailed analytics on SNT stock on TipRanks’ Stock Analysis page.